Moscatilin, a potential therapeutic agent for cancer treatment: insights into molecular mechanisms and clinical prospects

Medicine and Dentistry

• Anticarcinogen 100%
• Cancer Therapy 100%
• Bioavailability 100%
• Therapeutic Agent 100%
• Clinical Trial 50%
• Cancer Growth 50%
• Metastatic Carcinoma 50%
• Programmed Cell Death 50%
• Malignant Neoplasm 50%
• Combination Therapy 50%
• Traditional Chinese Medicine 50%
• Lung 50%
• Biological Activity 50%
• Proteus Syndrome 50%
• Stress Activated Protein Kinase 50%
• Colorectal Cancer 50%
• Pancreatic Cancer 50%
• Bibenzyl Derivative 50%
• Cell Proliferation 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Bioavailability 100%
• Malignant Neoplasm 100%
• Anticarcinogen 100%
• Dendrobium 100%
• Combination Therapy 50%
• Clinical Trial 50%
• Cancer Growth 50%
• Traditional Chinese Medicine 50%
• Multiple Cancer 50%
• Stress Activated Protein Kinase 50%
• Bibenzyl Derivative 50%

Biochemistry, Genetics and Molecular Biology

• Anticancer 100%
• Medline 40%
• Dendrobium 40%
• Programmed Cell Death 20%
• Biological Activity 20%
• Clinical Trial 20%
• Web of Science 20%
• C-Jun N-Terminal Kinases 20%
• Scopus 20%
• Cell Proliferation 20%